Australia health authority warns on falsified semaglutide pens
Reported from the analysis, not from a warning notice.
Archive — January 2025
Page 5 of 5 of this archive, newest first.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
A supplier suspends shipping to Poland after 11 consecutive customs detentions
The route did not close because of a rule about peptides.
Priming a pen is not optional
For licensed products the in-use period is established by stability data. For a peptide reconstituted at home there is no such data, and the honest answer is that nobody…
Why "muscle-sparing" is a marketing term and not a measurement
Grading six widely repeated claims against the studies actually behind them.
Randomised withdrawal is the cleanest design in this field and the least discussed
The evidence on stopping is better than the evidence on almost anything else in this field, because somebody deliberately randomised it.
What changed at WXT in January, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
The online reseller trading as Adamant Research Supply closes after 4 years
A proper account of an operation that existed, and of what closing it cost.
The 7-day notice: how a compounding wind-down works in Poland
The document is four pages. Three of them are about dates.